Replies to post #12249 on Sorrento Therapeutics Inc (SRNE)

[dia76ca]

Scilex potential is enormous. SP-103 and SP-104 have large markets. SEMDEXA has at least $3-5 billion potential in US alone for sciatica plus 10 potential uses outside of sciatica(knee, shoulder, wrist, ankle, joints) with an additional upside of 50-200%!
https://investors.sorrentotherapeutics.com/node/12901/html#tm2135241d1_ex99-1.htm